Gene expression profiling of antidepressant action in the brain

Implementing gene expression to study drug action in the central nervous system is complicated by functional heterogeneity because of the existence of many different neuronal subtypes within the mammalian brain. The integration of laser capture microdissection (LCM) and RNA amplification with cDNA m...

Full description

Saved in:
Bibliographic Details
Main Authors Bonaventure, Pascal, Quo, Hongqing, Liu, Xuejun, Kamme, Fredrik, Meurers, Bernhard, Leysen, Josepha, Bakker, Margot
Format Patent
LanguageEnglish
Published 24.10.2002
Online AccessGet full text

Cover

More Information
Summary:Implementing gene expression to study drug action in the central nervous system is complicated by functional heterogeneity because of the existence of many different neuronal subtypes within the mammalian brain. The integration of laser capture microdissection (LCM) and RNA amplification with cDNA microarray technology allows for large-scale gene expression analysis at cellular level. Using this approach, we have generated gene expression profiles of imipramine, a reference antidepressant, and a new putative antidepressant, novelR1 in several laser-captured brain nuclei (locus coeruleus, dorsal raphe, hypothalamic paraventricular nucleus and hippocampus) of rats subjected to the chronic mild stress model (CMS) of depression.